학술논문

Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study.
Document Type
Letter to the Editor
Source
Diabetes Care. May2023, Vol. 46 Issue 5, pe101-e102. 2p. 1 Chart.
Subject
*TYPE 1 diabetes
*INSULIN pumps
*DAPAGLIFLOZIN
*SODIUM-glucose cotransporter 2 inhibitors
*HYPERGLYCEMIA
Language
ISSN
0149-5992